Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Current evidence does not show that statins cause dementia, and large reviews suggest they may even be linked to a lower risk of cognitive decline by protecting blood vessels in the brain. Rare reports of fuzzy thinking or memory lapses have been noted, though these effects were mild, reversible after stopping or switching the drug, and never proven to be caused by statins. Because memory changes in an older adult are far more likely to stem from aging, other medications, sleep problems, thyroid issues, or early Alzheimer's disease, stopping a statin on your own can raise the risk of heart attack and stroke without fixing the real problem. There are several important factors and conversation tips to consider before making any changes, so see below to understand more.
If you are noticing new confusion, forgetfulness, or other symptoms in yourself or someone you care for, a free, instant, online symptom check can help you sort out which explanations fit best and what to raise with a doctor, so you walk into that appointment with clear questions instead of guesswork.
Last reviewed for medical accuracy: 09/29/2026
Statins are among the most commonly prescribed medications for lowering cholesterol and reducing the risk of heart attack and stroke. Yet concerns sometimes surface about whether statins might increase the risk of dementia or cause memory problems. Below, we’ll review what the science says, outline practical advice for caregivers, and suggest next steps if you or someone you care for has questions about statins and cognitive health.
Statins work by blocking an enzyme in the liver that helps produce cholesterol. By lowering “bad” LDL cholesterol, statins help:
Common statins include atorvastatin, simvastatin, rosuvastatin, and pravastatin.
Dementia is a general term for symptoms affecting memory, thinking, and social abilities severe enough to interfere with daily life. Alzheimer’s disease is the most common cause, but other forms include vascular dementia, Lewy body dementia, and frontotemporal dementia. Key points:
Multiple large studies have investigated whether taking statins increases dementia risk:
In 2012, the U.S. Food and Drug Administration (FDA) updated statin labels to mention rare reports of:
However, these side effects appear uncommon and typically resolve within weeks of stopping the medication. No evidence suggests they progress to permanent dementia.
Some research points to statins’ ability to:
While more studies are needed, these mechanisms offer biological plausibility for a protective effect against cognitive decline.
If you or a loved one notices memory lapses or confusion:
When discussing statins and dementia with someone you support, aim for clarity, reassurance, and empowerment:
Acknowledge Their Concerns
“I understand you’re worried about memory problems. Let’s look at what the research shows.”
Share the Key Facts
Emphasize Monitoring and Communication
“If you notice anything that feels off—like confusion or forgetfulness—let’s write it down, talk to your doctor, and maybe try the Ubie Symptom Checker to guide us.”
Encourage Shared Decision-Making
“We can discuss whether your dose needs adjusting or if another statin might suit you better. You’re in charge of your health, and your doctor is here to help.”
Offer Support
“I’ll come with you to appointments, help track any changes, and make sure your concerns are heard.”
Prompt medical attention is crucial if the person you care for experiences:
If any of these occur, do not wait—call a doctor or emergency services right away.
Current evidence does not support a link between statin use and lasting dementia. In fact, statins may offer protective benefits for brain health through improved circulation and reduced inflammation. Occasional, mild memory issues have been reported but are typically reversible and rare. The heart and brain are closely connected, and maintaining healthy cholesterol levels is a key part of overall well-being.
For personalized guidance, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. And remember: always talk to a doctor before making any changes to medication, especially if you suspect serious or life-threatening conditions. Your healthcare team is your best resource for tailored advice and peace of mind.
(References)
* Milani RV. Lipid and statin effects on stroke and dementia. Am J Geriatr Cardiol. 2004 May-Jun;13(3 Suppl 1):25-8. PMID: 15133426.
* Scheen AJ, Sadzot B. [Which indications for statins besides their cholesterol-lowering effect?]. Rev Med Suisse. 2005 Aug 24;1(30):1954, 1956-9. PMID: 16200939.
* Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):13-7. doi: 10.1136/jnnp.2008.150433. Epub 2008 Oct 17. PMID: 18931004.
* Kurata T, Miyazaki K, Kozuki M, Panin VL, Morimoto N, Ohta Y, Nagai M, Ikeda Y, Matsuura T, Abe K. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Brain Res. 2011 Jan 31;1371:161-70. doi: 10.1016/j.brainres.2010.11.067. Epub 2010 Nov 25. PMID: 21112317.
* Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2011 Aug 9;77(6):556-63. doi: 10.1212/WNL.0b013e318228bf11. Epub 2011 Jul 27. PMID: 21795660; PMCID: PMC3149154.
* Kumar A, Sharma N, Mishra J, Kalonia H. Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington's disease like symptoms and related cognitive dysfunction in rats. Eur J Pharmacol. 2013 Jun 5;709(1-3):1-12. doi: 10.1016/j.ejphar.2013.03.042. Epub 2013 Apr 3. PMID: 23562615.
* Zupanic E, Kramberger MG, von Euler M, Norrving B, Winblad B, Secnik J, Fastbom J, Eriksdotter M, Garcia-Ptacek S. Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders. J Alzheimers Dis. 2020;73(3):1013-1021. doi: 10.3233/JAD-191011. PMID: 31884483; PMCID: PMC7081091.
* Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, Patel S, Patel A, Patel V, Patel B. Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment. CNS Neurol Disord Drug Targets. 2023;22(10):1462-1471. doi: 10.2174/1871527322666221005124808. PMID: 36200162.
* Zhou X, Wu X, Wang R, Han L, Li H, Zhao W. Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease. Int J Mol Sci. 2023 Dec 22;25(1). doi: 10.3390/ijms25010170. Epub 2023 Dec 22. PMID: 38203341; PMCID: PMC10778631.
* Oliveira FF, Almeida SS, Chen ES, Bertolucci PHF, Smith MC. Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study. Sao Paulo Med J. 2025;143(4):e2024160. doi: 10.1590/1516-3180.2024.0160.27112024. Epub 2025 Aug 15. PMID: 40834163; PMCID: PMC12356643.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.